Skip to Content

C 745 (Glipizide Extended Release 5 mg)

Pill with imprint C 745 is Pink, Round and has been identified as Glipizide Extended Release 5 mg. It is supplied by Par Pharmaceutical, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 745

Glipizide Extended Release

Imprint
C 745
Strength
5 mg
Color
Pink
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical, Inc.
National Drug Code (NDC)
10370-0745
Inactive Ingredients
lactose anhydrous, butylated hydroxytoluene, cellulose acetate, silicon dioxide, glyceryl monostearate, hypromelloses, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:2), polyethylene glycol, polysorbate 80, propylene glycol, sodium chloride, sodium starch glycolate type A corn, ferrosoferric oxide, titanium dioxide, triacetin, FD&C Yellow No. 6, FD&C Red No. 40

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C 745"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.